This strategy suppresses neovascularization, reduces hypoxia-induced IGF-II secretion, enhances CD8+ T-cell infiltration, and creates a dual vascular-immune inhibition of the tumor microenvironment, thereby reversing tumor growth. This evidence concerns the gene IGF2 and neoplasm.